Roche’s Avastin prostate cancer study misses goal – Reuters
|
Roche's Avastin prostate cancer study misses goal
Reuters VX) said on Friday a late-stage study of its top-selling cancer drug Avastin failed to meet its primary objective of extending survival in men with advanced … Roche's Avastin Fails to Meet Goal of Prostate Study Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage … Roche Member Genentech Says Phase III Study Of Avastin In Men With Late Stage … |
